Full Press Release Details
Cybin to Present at the Jefferies London Healthcare Conference
TORONTO, CANADA November 11, 2021 Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ( Cybin
or the Company ), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM is pleased to announce that Doug Drysdale, Cybin s Chief
Executive Officer, will present virtually at the Jefferies London Healthcare Conference being held virtually November 18-19, 2021.
Mr. Drysdale s presentation will be available on demand beginning on Thursday, November 18, 2021 at 8:00 a.m. GMT/3:00 a.m. ET through Friday,
November 19, 2021 at 5:00pm GMT/12:00pm ET. To view the presentation, please click here to access the webcast. The archived webcast will also be available on the Company s investor relations website on the Events & Presentations
Cybin is a leading ethical
biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in
Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering
proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.
Investor & Media Contacts:
Vice President, Investor Relations
Tim Regan/Scott Eckstein
KCSA Strategic Communications
Communications, Inc.